

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | short-term memory (GO:0007614) | 7.86770130 |
| 2 | negative regulation of DNA repair (GO:0045738) | 7.50152237 |
| 3 | thyroid hormone generation (GO:0006590) | 7.00249121 |
| 4 | thyroid hormone metabolic process (GO:0042403) | 5.91214643 |
| 5 | negative regulation of amino acid transport (GO:0051956) | 5.43620996 |
| 6 | regulation of glutamate secretion (GO:0014048) | 4.96381364 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.83169458 |
| 8 | cell migration in hindbrain (GO:0021535) | 4.68212963 |
| 9 | negative regulation of microtubule polymerization (GO:0031115) | 4.62248815 |
| 10 | regulation of feeding behavior (GO:0060259) | 4.58259697 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.57692548 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 4.51545371 |
| 13 | urinary tract smooth muscle contraction (GO:0014848) | 4.44767161 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.42522445 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.33117359 |
| 16 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.32641801 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 4.30426835 |
| 18 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.29734357 |
| 19 | negative regulation of DNA recombination (GO:0045910) | 4.28953485 |
| 20 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.27992064 |
| 21 | regulation of glucocorticoid secretion (GO:2000849) | 4.27779511 |
| 22 | respiratory system process (GO:0003016) | 4.25058622 |
| 23 | dopaminergic neuron differentiation (GO:0071542) | 4.22815928 |
| 24 | axonal fasciculation (GO:0007413) | 4.22047712 |
| 25 | positive regulation of amino acid transport (GO:0051957) | 4.17645888 |
| 26 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.15359439 |
| 27 | neuron recognition (GO:0008038) | 4.12760149 |
| 28 | oxygen transport (GO:0015671) | 4.12075084 |
| 29 | response to gravity (GO:0009629) | 4.10458886 |
| 30 | positive regulation of membrane potential (GO:0045838) | 4.10013950 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.08334903 |
| 32 | ATP synthesis coupled proton transport (GO:0015986) | 4.05196431 |
| 33 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.05196431 |
| 34 | membrane repolarization (GO:0086009) | 4.04505917 |
| 35 | synaptic vesicle exocytosis (GO:0016079) | 4.03335697 |
| 36 | behavioral fear response (GO:0001662) | 3.95208647 |
| 37 | behavioral defense response (GO:0002209) | 3.95208647 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93341530 |
| 39 | protein localization to synapse (GO:0035418) | 3.92687771 |
| 40 | regulation of vesicle fusion (GO:0031338) | 3.90912662 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.89663125 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.88671505 |
| 43 | synaptic vesicle maturation (GO:0016188) | 3.84233990 |
| 44 | behavioral response to cocaine (GO:0048148) | 3.82609850 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 3.81696140 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.79189197 |
| 47 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.76526203 |
| 48 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.76492460 |
| 49 | membrane repolarization during action potential (GO:0086011) | 3.76041382 |
| 50 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.75720331 |
| 51 | inner mitochondrial membrane organization (GO:0007007) | 3.71998776 |
| 52 | vocalization behavior (GO:0071625) | 3.70145029 |
| 53 | cellular response to ATP (GO:0071318) | 3.69927528 |
| 54 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.69803068 |
| 55 | protein insertion into membrane (GO:0051205) | 3.69352679 |
| 56 | positive regulation of synapse assembly (GO:0051965) | 3.68485654 |
| 57 | respiratory electron transport chain (GO:0022904) | 3.66588350 |
| 58 | startle response (GO:0001964) | 3.66332809 |
| 59 | response to pheromone (GO:0019236) | 3.66171550 |
| 60 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.66032397 |
| 61 | electron transport chain (GO:0022900) | 3.63290214 |
| 62 | cerebellar granule cell differentiation (GO:0021707) | 3.60249855 |
| 63 | neurotransmitter secretion (GO:0007269) | 3.59907292 |
| 64 | neuron remodeling (GO:0016322) | 3.59224054 |
| 65 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.55565929 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.55325269 |
| 67 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.51070458 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.50174820 |
| 69 | * regulation of appetite (GO:0032098) | 3.50167132 |
| 70 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.49814971 |
| 71 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.47979523 |
| 72 | response to dietary excess (GO:0002021) | 3.47669419 |
| 73 | fear response (GO:0042596) | 3.46757980 |
| 74 | locomotory exploration behavior (GO:0035641) | 3.42958956 |
| 75 | neuromuscular process controlling posture (GO:0050884) | 3.41937628 |
| 76 | presynaptic membrane organization (GO:0097090) | 3.39084740 |
| 77 | gamma-aminobutyric acid transport (GO:0015812) | 3.38291084 |
| 78 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.38189705 |
| 79 | synaptic transmission, glutamatergic (GO:0035249) | 3.37890209 |
| 80 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.35996307 |
| 81 | sleep (GO:0030431) | 3.34860852 |
| 82 | inositol phosphate-mediated signaling (GO:0048016) | 3.34793424 |
| 83 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.32537745 |
| 84 | * positive regulation of amine transport (GO:0051954) | 3.32089501 |
| 85 | response to histamine (GO:0034776) | 3.29552397 |
| 86 | regulation of protein kinase A signaling (GO:0010738) | 3.26635715 |
| 87 | activation of protein kinase A activity (GO:0034199) | 3.26065953 |
| 88 | growth hormone secretion (GO:0030252) | 3.25755787 |
| 89 | negative regulation of hormone metabolic process (GO:0032351) | 3.24054896 |
| 90 | * neuropeptide signaling pathway (GO:0007218) | 3.22181395 |
| 91 | neuron-neuron synaptic transmission (GO:0007270) | 3.21307873 |
| 92 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21283132 |
| 93 | regulation of synapse assembly (GO:0051963) | 3.19148351 |
| 94 | negative regulation of amine transport (GO:0051953) | 3.17660735 |
| 95 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.17195384 |
| 96 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.15813054 |
| 97 | neurotransmitter transport (GO:0006836) | 3.14743832 |
| 98 | potassium ion import (GO:0010107) | 3.11808645 |
| 99 | positive regulation of meiosis (GO:0045836) | 3.10994903 |
| 100 | regulation of synaptic vesicle transport (GO:1902803) | 3.10526485 |
| 101 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.10401564 |
| 102 | axon extension (GO:0048675) | 3.08267191 |
| 103 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.07782831 |
| 104 | mating behavior (GO:0007617) | 3.06655695 |
| 105 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04138625 |
| 106 | positive regulation of gastrulation (GO:2000543) | 3.02704785 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00264016 |
| 108 | clathrin coat assembly (GO:0048268) | 2.99730840 |
| 109 | layer formation in cerebral cortex (GO:0021819) | 2.98074543 |
| 110 | regulation of amino acid transport (GO:0051955) | 2.96877157 |
| 111 | imidazole-containing compound metabolic process (GO:0052803) | 2.96797920 |
| 112 | artery smooth muscle contraction (GO:0014824) | 2.95322834 |
| 113 | potassium ion homeostasis (GO:0055075) | 2.94605821 |
| 114 | membrane depolarization (GO:0051899) | 2.93066273 |
| 115 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.92966109 |
| 116 | positive regulation of dendritic spine development (GO:0060999) | 2.92770564 |
| 117 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.92707980 |
| 118 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.91816800 |
| 119 | cerebellar Purkinje cell layer development (GO:0021680) | 2.91094327 |
| 120 | cell differentiation in hindbrain (GO:0021533) | 2.90430910 |
| 121 | proline transport (GO:0015824) | 2.90118989 |
| 122 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.89745611 |
| 123 | tachykinin receptor signaling pathway (GO:0007217) | 2.89649723 |
| 124 | atrial cardiac muscle cell action potential (GO:0086014) | 2.88298592 |
| 125 | positive regulation of meiotic cell cycle (GO:0051446) | 2.88034390 |
| 126 | regulation of neurotransmitter levels (GO:0001505) | 2.87787450 |
| 127 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.86982283 |
| 128 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.86982283 |
| 129 | regulation of dopamine secretion (GO:0014059) | 2.86184834 |
| 130 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.85389797 |
| 131 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.85389797 |
| 132 | dopamine receptor signaling pathway (GO:0007212) | 2.85297340 |
| 133 | detection of light stimulus involved in visual perception (GO:0050908) | 2.85220929 |
| 134 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.85220929 |
| 135 | social behavior (GO:0035176) | 2.84943767 |
| 136 | intraspecies interaction between organisms (GO:0051703) | 2.84943767 |
| 137 | cellular response to glucagon stimulus (GO:0071377) | 2.82531820 |
| 138 | exploration behavior (GO:0035640) | 2.82175995 |
| 139 | regulation of postsynaptic membrane potential (GO:0060078) | 2.82016942 |
| 140 | * feeding behavior (GO:0007631) | 2.81786991 |
| 141 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.81179813 |
| 142 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80603858 |
| 143 | positive regulation of action potential (GO:0045760) | 2.80433882 |
| 144 | glutamate secretion (GO:0014047) | 2.80430920 |
| 145 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.79785825 |
| 146 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.79683213 |
| 147 | opioid receptor signaling pathway (GO:0038003) | 2.75602549 |
| 148 | dendrite development (GO:0016358) | 2.74913984 |
| 149 | neurofilament cytoskeleton organization (GO:0060052) | 2.74797439 |
| 150 | neurotransmitter catabolic process (GO:0042135) | 2.74613267 |
| 151 | synapse assembly (GO:0007416) | 2.73459302 |
| 152 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.68482610 |
| 153 | dendrite morphogenesis (GO:0048813) | 2.66699601 |
| 154 | nerve growth factor signaling pathway (GO:0038180) | 2.65282423 |
| 155 | head development (GO:0060322) | 2.63063346 |
| 156 | nucleobase catabolic process (GO:0046113) | 2.62857679 |
| 157 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.62714296 |
| 158 | protein localization to cilium (GO:0061512) | 2.61558586 |
| 159 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.61063353 |
| 160 | regulation of axon guidance (GO:1902667) | 2.60059471 |
| 161 | forebrain neuron differentiation (GO:0021879) | 2.59592142 |
| 162 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.58995415 |
| 163 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.57526709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.85924754 |
| 2 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.16780745 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14522679 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14429044 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08366401 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.01249965 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.95954390 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.73832047 |
| 9 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.69557204 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.66740491 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.66558642 |
| 12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.64855621 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.63944745 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62354850 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62354850 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55894062 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55673163 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53300604 |
| 19 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.50843264 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.44361163 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.36809364 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32379478 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31902192 |
| 24 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.23642944 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19399640 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03090629 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97423300 |
| 28 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96348268 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90802322 |
| 30 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.86965154 |
| 31 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.86023531 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84029098 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83302711 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79566768 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76593184 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74661264 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71771751 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.67095278 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66616260 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65889371 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63026239 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62553555 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.61642968 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60231541 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56349114 |
| 46 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.53795314 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53628122 |
| 48 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48199016 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44732418 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42968947 |
| 51 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42754331 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39696904 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35631281 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34832231 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34502352 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33245191 |
| 57 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.31929452 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31692044 |
| 59 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30662433 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27692449 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25831753 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24710530 |
| 63 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.22651791 |
| 64 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21272458 |
| 65 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15412679 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14653615 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14172786 |
| 68 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13436788 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13198633 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12523769 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11904893 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11616197 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10685186 |
| 74 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10355653 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10266321 |
| 76 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09543524 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09257355 |
| 78 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09250811 |
| 79 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08897338 |
| 80 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.08840823 |
| 81 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.08267737 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08243359 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08243359 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08124387 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08124387 |
| 86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05786795 |
| 87 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05524423 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05290823 |
| 89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05235311 |
| 90 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.05179356 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04597182 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02269232 |
| 93 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01081715 |
| 94 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00985972 |
| 95 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00845102 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00619959 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00177844 |
| 98 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99878927 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99267544 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99183194 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98882418 |
| 102 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97938244 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96639212 |
| 104 | * JUN_21703547_ChIP-Seq_K562_Human | 0.96576203 |
| 105 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96325951 |
| 106 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.95689944 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95371497 |
| 108 | AR_19668381_ChIP-Seq_PC3_Human | 0.94347540 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94263543 |
| 110 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93994193 |
| 111 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93989588 |
| 112 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93029441 |
| 113 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.92922727 |
| 114 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92836765 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92313525 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91714601 |
| 117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91388403 |
| 118 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91170879 |
| 119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90971607 |
| 120 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90163610 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89834272 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89834272 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89072952 |
| 124 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88489358 |
| 125 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87529318 |
| 126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86922551 |
| 127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86304246 |
| 128 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82197826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003122_maternal_imprinting | 5.28953636 |
| 2 | MP0003880_abnormal_central_pattern | 4.18370012 |
| 3 | MP0006276_abnormal_autonomic_nervous | 3.82820772 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 3.49137102 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.39010070 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.30767164 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.08392900 |
| 8 | MP0001984_abnormal_olfaction | 3.04757993 |
| 9 | MP0002064_seizures | 2.66182164 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.65950918 |
| 11 | MP0009745_abnormal_behavioral_response | 2.56069275 |
| 12 | MP0004270_analgesia | 2.54704296 |
| 13 | MP0003121_genomic_imprinting | 2.46014127 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.45632853 |
| 15 | MP0001440_abnormal_grooming_behavior | 2.40552753 |
| 16 | MP0001188_hyperpigmentation | 2.39744756 |
| 17 | MP0001529_abnormal_vocalization | 2.26651488 |
| 18 | MP0000751_myopathy | 2.22264815 |
| 19 | MP0000681_abnormal_thyroid_gland | 2.19967818 |
| 20 | MP0009046_muscle_twitch | 2.17878627 |
| 21 | MP0004142_abnormal_muscle_tone | 2.17461806 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.15354222 |
| 23 | MP0002822_catalepsy | 2.12716241 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.09730039 |
| 25 | MP0002733_abnormal_thermal_nociception | 2.00652810 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.99538874 |
| 27 | MP0002272_abnormal_nervous_system | 1.96800609 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.92457312 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.89874903 |
| 30 | MP0000778_abnormal_nervous_system | 1.89760523 |
| 31 | MP0004043_abnormal_pH_regulation | 1.88569767 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.88502820 |
| 33 | MP0002184_abnormal_innervation | 1.88323342 |
| 34 | MP0003879_abnormal_hair_cell | 1.85526928 |
| 35 | MP0001970_abnormal_pain_threshold | 1.83758967 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.79787577 |
| 37 | MP0004924_abnormal_behavior | 1.79787577 |
| 38 | MP0005083_abnormal_biliary_tract | 1.79739881 |
| 39 | MP0000383_abnormal_hair_follicle | 1.76370418 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.74417254 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.73969847 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.73428972 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.71885801 |
| 44 | MP0003123_paternal_imprinting | 1.65236599 |
| 45 | MP0003329_amyloid_beta_deposits | 1.59594790 |
| 46 | MP0001486_abnormal_startle_reflex | 1.58231686 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.56976593 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.54563124 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.54247758 |
| 50 | MP0001905_abnormal_dopamine_level | 1.51116850 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.47158830 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.39759064 |
| 53 | MP0002736_abnormal_nociception_after | 1.38810903 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.38313424 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.37993827 |
| 56 | MP0000566_synostosis | 1.30567215 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.30413155 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.30328149 |
| 59 | MP0004510_myositis | 1.30010615 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.27730046 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.26631948 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.25367327 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.25043442 |
| 64 | MP0000538_abnormal_urinary_bladder | 1.20336699 |
| 65 | MP0008872_abnormal_physiological_respon | 1.15311579 |
| 66 | MP0002234_abnormal_pharynx_morphology | 1.14058500 |
| 67 | MP0003787_abnormal_imprinting | 1.13751808 |
| 68 | * MP0002069_abnormal_eating/drinking_beha | 1.11436530 |
| 69 | MP0002332_abnormal_exercise_endurance | 1.10496934 |
| 70 | MP0005409_darkened_coat_color | 1.09784847 |
| 71 | MP0000955_abnormal_spinal_cord | 1.09214198 |
| 72 | * MP0005448_abnormal_energy_balance | 1.09107428 |
| 73 | MP0003632_abnormal_nervous_system | 1.03509446 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 1.03300883 |
| 75 | MP0005379_endocrine/exocrine_gland_phen | 0.99582412 |
| 76 | MP0000747_muscle_weakness | 0.99058985 |
| 77 | MP0003959_abnormal_lean_body | 0.98141705 |
| 78 | MP0002152_abnormal_brain_morphology | 0.97630159 |
| 79 | MP0008260_abnormal_autophagy | 0.92753700 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.92214958 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.91318103 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.90189033 |
| 83 | MP0008995_early_reproductive_senescence | 0.87571683 |
| 84 | MP0003011_delayed_dark_adaptation | 0.86997340 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86309230 |
| 86 | MP0000604_amyloidosis | 0.85889249 |
| 87 | MP0002751_abnormal_autonomic_nervous | 0.85639185 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.85053800 |
| 89 | MP0000026_abnormal_inner_ear | 0.78394906 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.78309063 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.76792104 |
| 92 | MP0002163_abnormal_gland_morphology | 0.75444242 |
| 93 | MP0004133_heterotaxia | 0.74112383 |
| 94 | * MP0005452_abnormal_adipose_tissue | 0.73957338 |
| 95 | MP0003868_abnormal_feces_composition | 0.73139541 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.72270731 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.72057040 |
| 98 | MP0004885_abnormal_endolymph | 0.71929858 |
| 99 | MP0003690_abnormal_glial_cell | 0.71043323 |
| 100 | MP0008569_lethality_at_weaning | 0.70956507 |
| 101 | MP0002938_white_spotting | 0.70894536 |
| 102 | MP0001177_atelectasis | 0.70666482 |
| 103 | MP0004085_abnormal_heartbeat | 0.69655989 |
| 104 | MP0005535_abnormal_body_temperature | 0.68304069 |
| 105 | MP0004742_abnormal_vestibular_system | 0.68046417 |
| 106 | MP0002229_neurodegeneration | 0.67924779 |
| 107 | MP0003948_abnormal_gas_homeostasis | 0.67836695 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.67637002 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.67481672 |
| 110 | MP0000462_abnormal_digestive_system | 0.67372073 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.66820895 |
| 112 | MP0005253_abnormal_eye_physiology | 0.66649653 |
| 113 | MP0003283_abnormal_digestive_organ | 0.65198400 |
| 114 | MP0001664_abnormal_digestion | 0.64203341 |
| 115 | MP0001943_abnormal_respiration | 0.64053465 |
| 116 | MP0003633_abnormal_nervous_system | 0.63905054 |
| 117 | * MP0002078_abnormal_glucose_homeostasis | 0.63873237 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.63694321 |
| 119 | MP0002102_abnormal_ear_morphology | 0.61996227 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.61347984 |
| 121 | MP0003938_abnormal_ear_development | 0.59687839 |
| 122 | MP0004858_abnormal_nervous_system | 0.59526364 |
| 123 | MP0010770_preweaning_lethality | 0.59396014 |
| 124 | MP0002082_postnatal_lethality | 0.59396014 |
| 125 | MP0003631_nervous_system_phenotype | 0.58631334 |
| 126 | MP0004883_abnormal_blood_vessel | 0.58039771 |
| 127 | MP0003634_abnormal_glial_cell | 0.57126758 |
| 128 | MP0000920_abnormal_myelination | 0.56677227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polyphagia (HP:0002591) | 5.65735831 |
| 2 | Myokymia (HP:0002411) | 5.30332447 |
| 3 | Goiter (HP:0000853) | 5.28629076 |
| 4 | Failure to thrive in infancy (HP:0001531) | 4.94754416 |
| 5 | Thyroid-stimulating hormone excess (HP:0002925) | 4.64969112 |
| 6 | Focal seizures (HP:0007359) | 4.55110534 |
| 7 | Focal motor seizures (HP:0011153) | 4.50415080 |
| 8 | Pheochromocytoma (HP:0002666) | 4.14892260 |
| 9 | Abnormal eating behavior (HP:0100738) | 4.08526967 |
| 10 | Atonic seizures (HP:0010819) | 3.97468892 |
| 11 | Absence seizures (HP:0002121) | 3.94829870 |
| 12 | Neuroendocrine neoplasm (HP:0100634) | 3.78974362 |
| 13 | Poor suck (HP:0002033) | 3.57420538 |
| 14 | Abnormality of the labia minora (HP:0012880) | 3.52760136 |
| 15 | Oligomenorrhea (HP:0000876) | 3.48671277 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.45586156 |
| 17 | Febrile seizures (HP:0002373) | 3.44480852 |
| 18 | Hypoglycemic seizures (HP:0002173) | 3.33744216 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.30120463 |
| 20 | Congenital sensorineural hearing impairment (HP:0008527) | 3.30070150 |
| 21 | Epileptic encephalopathy (HP:0200134) | 3.26775681 |
| 22 | Dialeptic seizures (HP:0011146) | 3.25155255 |
| 23 | Abnormality of the corticospinal tract (HP:0002492) | 3.19803218 |
| 24 | Visual hallucinations (HP:0002367) | 3.15367316 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 3.14061381 |
| 26 | Hypoventilation (HP:0002791) | 3.09728836 |
| 27 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.09719031 |
| 28 | Narrow nasal bridge (HP:0000446) | 3.08816600 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 3.07588231 |
| 30 | Congenital stationary night blindness (HP:0007642) | 3.06172190 |
| 31 | Abnormal hair whorl (HP:0010721) | 3.05635502 |
| 32 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.01267949 |
| 33 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.01267949 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 2.99934134 |
| 35 | Progressive macrocephaly (HP:0004481) | 2.97454817 |
| 36 | Delayed epiphyseal ossification (HP:0002663) | 2.97300496 |
| 37 | Esotropia (HP:0000565) | 2.97160533 |
| 38 | Sleep apnea (HP:0010535) | 2.96960549 |
| 39 | Anxiety (HP:0000739) | 2.94027571 |
| 40 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.89322298 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.84340732 |
| 42 | Acute encephalopathy (HP:0006846) | 2.82311605 |
| 43 | Impaired pain sensation (HP:0007328) | 2.79127668 |
| 44 | Abnormality of pain sensation (HP:0010832) | 2.79127668 |
| 45 | Limb dystonia (HP:0002451) | 2.76804300 |
| 46 | Symptomatic seizures (HP:0011145) | 2.75700933 |
| 47 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.74160233 |
| 48 | Generalized hypotonia (HP:0001290) | 2.72890356 |
| 49 | Agitation (HP:0000713) | 2.70978229 |
| 50 | Spastic gait (HP:0002064) | 2.70837601 |
| 51 | Tented upper lip vermilion (HP:0010804) | 2.70583854 |
| 52 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.69844867 |
| 53 | Broad alveolar ridges (HP:0000187) | 2.69555999 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.65863954 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.62173175 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.62173175 |
| 57 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.55742494 |
| 58 | Mutism (HP:0002300) | 2.54514956 |
| 59 | Drooling (HP:0002307) | 2.52748396 |
| 60 | Hyperventilation (HP:0002883) | 2.51565372 |
| 61 | Hypothermia (HP:0002045) | 2.51488866 |
| 62 | Focal dystonia (HP:0004373) | 2.50337400 |
| 63 | Abnormality of cochlea (HP:0000375) | 2.50282038 |
| 64 | Truncal ataxia (HP:0002078) | 2.49413424 |
| 65 | Hyperthyroidism (HP:0000836) | 2.48467831 |
| 66 | Nephronophthisis (HP:0000090) | 2.43780944 |
| 67 | Pili torti (HP:0003777) | 2.39045995 |
| 68 | Thyroid carcinoma (HP:0002890) | 2.38085572 |
| 69 | Neurofibrillary tangles (HP:0002185) | 2.36461798 |
| 70 | Abnormal pancreas size (HP:0012094) | 2.36361127 |
| 71 | Excessive salivation (HP:0003781) | 2.33586556 |
| 72 | Broad-based gait (HP:0002136) | 2.33527948 |
| 73 | Optic disc pallor (HP:0000543) | 2.33263335 |
| 74 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.33143366 |
| 75 | Psychosis (HP:0000709) | 2.33128248 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.33069363 |
| 77 | Gait imbalance (HP:0002141) | 2.31673430 |
| 78 | Hyperparathyroidism (HP:0000843) | 2.31247919 |
| 79 | Prolonged QT interval (HP:0001657) | 2.30314373 |
| 80 | Termporal pattern (HP:0011008) | 2.30280224 |
| 81 | Insidious onset (HP:0003587) | 2.30280224 |
| 82 | Abnormal EKG (HP:0003115) | 2.28561535 |
| 83 | Akinesia (HP:0002304) | 2.25460439 |
| 84 | Abnormal pupillary function (HP:0007686) | 2.24029125 |
| 85 | Rimmed vacuoles (HP:0003805) | 2.23584139 |
| 86 | Shoulder girdle muscle weakness (HP:0003547) | 2.22316994 |
| 87 | Parakeratosis (HP:0001036) | 2.21615776 |
| 88 | Anosmia (HP:0000458) | 2.21228274 |
| 89 | Ankle clonus (HP:0011448) | 2.20813050 |
| 90 | Large eyes (HP:0001090) | 2.20478551 |
| 91 | Palpitations (HP:0001962) | 2.19918512 |
| 92 | Action tremor (HP:0002345) | 2.19820640 |
| 93 | Menstrual irregularities (HP:0000858) | 2.19005826 |
| 94 | Diaphragmatic weakness (HP:0009113) | 2.17727240 |
| 95 | Mild short stature (HP:0003502) | 2.16932661 |
| 96 | Prominent supraorbital ridges (HP:0000336) | 2.14389178 |
| 97 | Small epiphyses (HP:0010585) | 2.13125414 |
| 98 | Macroglossia (HP:0000158) | 2.12708799 |
| 99 | Abnormal ciliary motility (HP:0012262) | 2.12654147 |
| 100 | Hepatic necrosis (HP:0002605) | 2.11959012 |
| 101 | Cerebral edema (HP:0002181) | 2.11538234 |
| 102 | Specific learning disability (HP:0001328) | 2.11535223 |
| 103 | Chronic hepatic failure (HP:0100626) | 2.07802112 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.07744528 |
| 105 | Amblyopia (HP:0000646) | 2.06572986 |
| 106 | Unilateral renal agenesis (HP:0000122) | 2.06392961 |
| 107 | Depression (HP:0000716) | 2.04870559 |
| 108 | Nasal speech (HP:0001611) | 2.04232037 |
| 109 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.03013365 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 2.02922720 |
| 111 | Testicular neoplasm (HP:0010788) | 2.02477398 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02275822 |
| 113 | Urinary urgency (HP:0000012) | 2.02213740 |
| 114 | Leukodystrophy (HP:0002415) | 2.02107094 |
| 115 | Abnormality of macular pigmentation (HP:0008002) | 2.01633026 |
| 116 | Morphological abnormality of the inner ear (HP:0011390) | 2.01209163 |
| 117 | Hypsarrhythmia (HP:0002521) | 1.97875488 |
| 118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.97491969 |
| 119 | Bronchomalacia (HP:0002780) | 1.96801596 |
| 120 | Epileptiform EEG discharges (HP:0011182) | 1.95971735 |
| 121 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94235563 |
| 122 | Large for gestational age (HP:0001520) | 1.93988273 |
| 123 | Palpebral edema (HP:0100540) | 1.93401593 |
| 124 | Increased muscle lipid content (HP:0009058) | 1.92692206 |
| 125 | Dysmetria (HP:0001310) | 1.92543747 |
| 126 | True hermaphroditism (HP:0010459) | 1.91099339 |
| 127 | Clonus (HP:0002169) | 1.90727038 |
| 128 | Status epilepticus (HP:0002133) | 1.90462783 |
| 129 | Cerebral aneurysm (HP:0004944) | 1.90223851 |
| 130 | Neonatal onset (HP:0003623) | 1.88159909 |
| 131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.87272159 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.87167869 |
| 133 | Central scotoma (HP:0000603) | 1.86785078 |
| 134 | Intellectual disability, progressive (HP:0006887) | 1.86110835 |
| 135 | Dysdiadochokinesis (HP:0002075) | 1.84668923 |
| 136 | Diplopia (HP:0000651) | 1.84576711 |
| 137 | Abnormality of binocular vision (HP:0011514) | 1.84576711 |
| 138 | Hepatocellular necrosis (HP:0001404) | 1.83824800 |
| 139 | Shawl scrotum (HP:0000049) | 1.83798670 |
| 140 | Hypoplastic ischia (HP:0003175) | 1.83749836 |
| 141 | Generalized myoclonic seizures (HP:0002123) | 1.83513430 |
| 142 | Hypercortisolism (HP:0001578) | 1.83081919 |
| 143 | Tetraplegia (HP:0002445) | 1.82689168 |
| 144 | Labial hypoplasia (HP:0000066) | 1.82157753 |
| 145 | Ventricular fibrillation (HP:0001663) | 1.82059011 |
| 146 | Occipital encephalocele (HP:0002085) | 1.81996967 |
| 147 | Pancreatic fibrosis (HP:0100732) | 1.81828160 |
| 148 | Torticollis (HP:0000473) | 1.81021518 |
| 149 | Hoarse voice (HP:0001609) | 1.80760365 |
| 150 | Atrial fibrillation (HP:0005110) | 1.80603796 |
| 151 | Lower limb muscle weakness (HP:0007340) | 1.80402393 |
| 152 | Delayed gross motor development (HP:0002194) | 1.80342479 |
| 153 | Postural instability (HP:0002172) | 1.79700422 |
| 154 | Coarse facial features (HP:0000280) | 1.78679401 |
| 155 | Papilledema (HP:0001085) | 1.77069486 |
| 156 | Heterochromia iridis (HP:0001100) | 1.76584055 |
| 157 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76099009 |
| 158 | Craniofacial dystonia (HP:0012179) | 1.75383892 |
| 159 | Protruding tongue (HP:0010808) | 1.74622991 |
| 160 | Progressive inability to walk (HP:0002505) | 1.73830388 |
| 161 | Primary atrial arrhythmia (HP:0001692) | 1.73515677 |
| 162 | Sporadic (HP:0003745) | 1.73013099 |
| 163 | Increased CSF lactate (HP:0002490) | 1.72943271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.83599106 |
| 2 | TAOK3 | 4.73431228 |
| 3 | MAP3K12 | 4.59425783 |
| 4 | NTRK3 | 3.67001307 |
| 5 | PNCK | 2.99158309 |
| 6 | UHMK1 | 2.84874324 |
| 7 | MAP3K9 | 2.84510345 |
| 8 | NTRK2 | 2.68324664 |
| 9 | MAP2K4 | 2.46613195 |
| 10 | NME1 | 2.35712805 |
| 11 | WNK3 | 2.31416518 |
| 12 | MINK1 | 2.25226124 |
| 13 | MAPK13 | 2.22436206 |
| 14 | MAP3K4 | 2.18886266 |
| 15 | BMPR1B | 2.05127969 |
| 16 | CAMKK2 | 1.92569848 |
| 17 | PHKG1 | 1.88549227 |
| 18 | PHKG2 | 1.88549227 |
| 19 | PAK3 | 1.81756199 |
| 20 | CASK | 1.78205151 |
| 21 | FES | 1.70461441 |
| 22 | IRAK2 | 1.69747941 |
| 23 | PAK6 | 1.68504673 |
| 24 | CAMK1G | 1.65162834 |
| 25 | MAP2K7 | 1.62931740 |
| 26 | BCR | 1.55863855 |
| 27 | MAP3K6 | 1.54384079 |
| 28 | DYRK2 | 1.51794011 |
| 29 | TAF1 | 1.51021721 |
| 30 | CDK19 | 1.40924010 |
| 31 | CDK8 | 1.30005238 |
| 32 | TNIK | 1.26672233 |
| 33 | CDK5 | 1.24117985 |
| 34 | ARAF | 1.18714670 |
| 35 | MKNK2 | 1.18093470 |
| 36 | KSR1 | 1.11924560 |
| 37 | ACVR1B | 1.10171241 |
| 38 | PRKCG | 1.09249683 |
| 39 | CAMK2B | 1.08739682 |
| 40 | ADRBK1 | 1.07699016 |
| 41 | STK38 | 1.05686517 |
| 42 | PINK1 | 1.01884976 |
| 43 | CAMK2A | 0.98121317 |
| 44 | MAP3K11 | 0.96685712 |
| 45 | CSNK1G2 | 0.96428308 |
| 46 | LIMK1 | 0.95782968 |
| 47 | CDK14 | 0.95412344 |
| 48 | ALK | 0.94498158 |
| 49 | MAP2K6 | 0.94127701 |
| 50 | CDK18 | 0.94059808 |
| 51 | SIK3 | 0.92912876 |
| 52 | CAMK2G | 0.92852615 |
| 53 | CAMKK1 | 0.92711768 |
| 54 | ERBB3 | 0.90989659 |
| 55 | GRK5 | 0.90696451 |
| 56 | SGK223 | 0.88274955 |
| 57 | SGK494 | 0.88274955 |
| 58 | CDK15 | 0.87037452 |
| 59 | PLK2 | 0.86349127 |
| 60 | OXSR1 | 0.85755863 |
| 61 | MAPK4 | 0.85256399 |
| 62 | DYRK1A | 0.84101395 |
| 63 | GRK7 | 0.83820560 |
| 64 | CSNK1G3 | 0.81822111 |
| 65 | AKT3 | 0.80851253 |
| 66 | CAMK1D | 0.79227210 |
| 67 | CAMK1 | 0.79169328 |
| 68 | CDK11A | 0.76523535 |
| 69 | TGFBR1 | 0.76160880 |
| 70 | MAP3K5 | 0.76105154 |
| 71 | CAMK2D | 0.71578326 |
| 72 | SGK2 | 0.69252870 |
| 73 | DAPK1 | 0.67532546 |
| 74 | TYRO3 | 0.64429438 |
| 75 | FGFR2 | 0.60988995 |
| 76 | ADRBK2 | 0.60645718 |
| 77 | MARK2 | 0.60310904 |
| 78 | ZAK | 0.58679012 |
| 79 | DAPK2 | 0.58022968 |
| 80 | CSNK1A1L | 0.58000385 |
| 81 | SIK2 | 0.57826257 |
| 82 | EPHA4 | 0.57777555 |
| 83 | STK16 | 0.57200881 |
| 84 | TLK1 | 0.56596119 |
| 85 | LRRK2 | 0.54840891 |
| 86 | MAPK15 | 0.54203080 |
| 87 | GRK1 | 0.53239896 |
| 88 | INSRR | 0.52661091 |
| 89 | CSNK1G1 | 0.52654824 |
| 90 | PRKCZ | 0.50751799 |
| 91 | PRKD2 | 0.50473740 |
| 92 | LATS2 | 0.49546098 |
| 93 | MAP3K10 | 0.48766021 |
| 94 | PRKG2 | 0.48731368 |
| 95 | RIPK4 | 0.48648813 |
| 96 | MST1R | 0.48105541 |
| 97 | PKN1 | 0.47130063 |
| 98 | CSNK1E | 0.47074322 |
| 99 | MAP4K2 | 0.43551315 |
| 100 | SCYL2 | 0.43510796 |
| 101 | FYN | 0.43473107 |
| 102 | PRKACA | 0.43080440 |
| 103 | NTRK1 | 0.42207553 |
| 104 | RET | 0.41849817 |
| 105 | KSR2 | 0.41049224 |
| 106 | TSSK6 | 0.40989046 |
| 107 | BCKDK | 0.40209917 |
| 108 | PRKCE | 0.39771157 |
| 109 | CAMK4 | 0.39145679 |
| 110 | LMTK2 | 0.38947432 |
| 111 | TESK1 | 0.38237118 |
| 112 | PRKG1 | 0.38186745 |
| 113 | FRK | 0.38169569 |
| 114 | BMPR2 | 0.37916519 |
| 115 | MST4 | 0.37615136 |
| 116 | MAP2K1 | 0.36976758 |
| 117 | EPHB2 | 0.34719325 |
| 118 | PRKCB | 0.34367873 |
| 119 | PDK1 | 0.34083650 |
| 120 | DAPK3 | 0.33364256 |
| 121 | ROCK2 | 0.33218516 |
| 122 | SGK1 | 0.33019466 |
| 123 | PRKACG | 0.32816113 |
| 124 | MAPK9 | 0.32170087 |
| 125 | RPS6KA3 | 0.31740509 |
| 126 | IRAK1 | 0.31701845 |
| 127 | MOS | 0.31616874 |
| 128 | PAK2 | 0.31403129 |
| 129 | BRAF | 0.29692576 |
| 130 | MAP3K1 | 0.29216510 |
| 131 | MAPK12 | 0.28914065 |
| 132 | HIPK2 | 0.28661603 |
| 133 | TNK2 | 0.28593040 |
| 134 | TIE1 | 0.28532978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.15497947 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.03318767 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.47834714 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.17090782 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.06318014 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.79757941 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66120310 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.65939262 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.60515992 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.57260304 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.39517018 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18770141 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.03228453 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.03192969 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96525165 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90375556 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.89628867 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.89380684 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.88837912 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.77945409 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71871969 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.58960233 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.56019002 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55275837 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54627617 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.49681759 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.43834010 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.34314614 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.32655445 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22335949 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22111233 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.20184801 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19634614 |
| 34 | Axon guidance_Homo sapiens_hsa04360 | 1.17713262 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14677201 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13969182 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12630913 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12295939 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.11462048 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08756045 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.03234072 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02118248 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99986927 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 0.96406307 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95946938 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 0.92694301 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91594145 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89306452 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.88849382 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88032515 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85749004 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82833105 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82502844 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79456457 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79172283 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78514538 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78185986 |
| 58 | Alcoholism_Homo sapiens_hsa05034 | 0.75253875 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73565361 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73387463 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70890200 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70627212 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.70598667 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69628801 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64969867 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62800424 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62676385 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62052031 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61453586 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60011873 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57338288 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56961369 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56436555 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56267360 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54506265 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53854115 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53182291 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50440711 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50116639 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50111791 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.48538063 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47901735 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47227846 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46563778 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46199356 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45581428 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44492920 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44374434 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.43243749 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43003376 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38658902 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.37700722 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37691640 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35845694 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34771050 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.34444227 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34243799 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34205756 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34053752 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33861397 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33808740 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33019904 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32898375 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31399839 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31207946 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31122435 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30616652 |
| 108 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29438941 |
| 109 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28858555 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28228066 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28045397 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27969433 |
| 113 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27105409 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27036896 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26960729 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26747598 |
| 117 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25894758 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24719435 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24617788 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24497733 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.24350430 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.23633623 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22283966 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.22263839 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21094261 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21034527 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.19811433 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16039499 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.14003119 |
| 130 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.13576008 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.13045743 |
| 132 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.11721471 |

